DK207379A - Technetium-99-maerket anti-humant-choriongonadotropin, technetium-99m-maerket anti-humant-choriongonadotropin-beta eller blandinger deraf samt diagnostisk saet til fremstilling af et middel til identifikation af en cancercelle og eller en malign t - Google Patents

Technetium-99-maerket anti-humant-choriongonadotropin, technetium-99m-maerket anti-humant-choriongonadotropin-beta eller blandinger deraf samt diagnostisk saet til fremstilling af et middel til identifikation af en cancercelle og eller en malign t

Info

Publication number
DK207379A
DK207379A DK207379A DK207379A DK207379A DK 207379 A DK207379 A DK 207379A DK 207379 A DK207379 A DK 207379A DK 207379 A DK207379 A DK 207379A DK 207379 A DK207379 A DK 207379A
Authority
DK
Denmark
Prior art keywords
choriongonadotropine
humant
technetium
labeled anti
beta
Prior art date
Application number
DK207379A
Other languages
English (en)
Inventor
D R Crockford
B A Rhodes
Mor
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of DK207379A publication Critical patent/DK207379A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1024—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against hormones, hormone-releasing or hormone-inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK207379A 1978-05-22 1979-05-21 Technetium-99-maerket anti-humant-choriongonadotropin, technetium-99m-maerket anti-humant-choriongonadotropin-beta eller blandinger deraf samt diagnostisk saet til fremstilling af et middel til identifikation af en cancercelle og eller en malign t DK207379A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90856878A 1978-05-22 1978-05-22
US06/037,992 US4323546A (en) 1978-05-22 1979-05-14 Method and composition for cancer detection in humans

Publications (1)

Publication Number Publication Date
DK207379A true DK207379A (da) 1979-11-23

Family

ID=26714695

Family Applications (1)

Application Number Title Priority Date Filing Date
DK207379A DK207379A (da) 1978-05-22 1979-05-21 Technetium-99-maerket anti-humant-choriongonadotropin, technetium-99m-maerket anti-humant-choriongonadotropin-beta eller blandinger deraf samt diagnostisk saet til fremstilling af et middel til identifikation af en cancercelle og eller en malign t

Country Status (6)

Country Link
US (1) US4323546A (da)
EP (1) EP0005638B1 (da)
CA (1) CA1116081A (da)
DE (1) DE2966177D1 (da)
DK (1) DK207379A (da)
IL (1) IL57348A (da)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350537A (en) * 1979-10-17 1982-09-21 Itt Industries Inc. Semiconductor annealing by pulsed heating
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4460561A (en) * 1980-03-03 1984-07-17 Goldenberg M David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4460559A (en) * 1980-03-03 1984-07-17 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
DE3239410A1 (de) * 1981-10-27 1983-05-19 Hybritech Inc., 92121 San Diego, Calif. Monoklonale antikoerper zu tumorassoziiertem antigen, zusammensetzungen, welche diese enthalten und deren anwendung zum tumornachweis
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4574079A (en) * 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
EP0149709B2 (en) * 1983-07-29 1995-11-29 Milton David Goldenberg Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
US4624846A (en) * 1983-07-29 1986-11-25 Immunomedics, Inc. Method for enhancing target specificity of antibody localization and clearance of non-target diagnostic and therapeutic principles
JPS61501087A (ja) * 1983-12-29 1986-05-29 オ−ストラリア国 テクネチウム−９９ｍ−標識放射医薬の製造
US4674480A (en) * 1984-05-25 1987-06-23 Lemelson Jerome H Drug compositions and methods of applying same
US4665897A (en) * 1984-05-25 1987-05-19 Lemelson Jerome H Composition and method for detecting and treating cancer
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4937067A (en) * 1984-12-13 1990-06-26 Massachusetts Institute Of Technology Method and means for detection of adrenal metabolic activity
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
WO1987004164A1 (en) * 1986-01-06 1987-07-16 The University Of Melbourne Technetium-antibody conjugate
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5128119A (en) * 1989-06-12 1992-07-07 Immunomedics, Inc. Methods for technetium/rhenium labeling of f(ab1)2 fragments
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
US5102990A (en) * 1989-08-09 1992-04-07 Rhomed Incorporated Direct radiolabeling of antibodies and other proteins with technetium or rhenium
CA1340250C (en) * 1989-09-18 1998-12-15 Hans J. Hansen Method for rapidly radiolabeling monovalent antibody fragments with technetium
EP0516873A1 (en) * 1991-06-06 1992-12-09 THE STATE of ISRAEL Atomic Energy Commission Soreq Nuclear Research Center A method and kit for protein labelling with 99 mTC
JPH07506830A (ja) * 1992-05-15 1995-07-27 マリンクロット・メディカル・インコーポレイテッド 炎症検出用診断剤の製造法
US5746996A (en) * 1994-06-03 1998-05-05 Immunomedics, Inc. Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
IL113610A0 (en) * 1994-06-03 1995-08-31 Immunomedics Inc A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US20080194022A1 (en) * 2000-08-03 2008-08-14 Clarke Michael F Isolation and use of solid tumor stem cells
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
AU2003201741A1 (en) 2002-01-09 2003-07-24 Yusuke Nakamura Cancer profiles
EP2481814A3 (en) * 2003-06-09 2012-10-10 The Regents of the University of Michigan Compositions and methods for treating and diagnosing cancer
WO2005074633A2 (en) * 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CA2612021A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) * 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
WO2007047907A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of Michigan Dek protein compositions and methods of using the same
EP2511298B1 (en) 2005-10-31 2019-01-16 Oncomed Pharmaceuticals, Inc. Compositions and Methods for Treating Cancer based on human FZD receptors
JP5129149B2 (ja) * 2005-10-31 2013-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 癌を処置および診断するための組成物および方法
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
EP1998785A4 (en) * 2006-02-21 2009-06-17 Univ Michigan CANCER TREATMENT USING A HEDGEHOG SIGNALING PATH
WO2008045952A2 (en) * 2006-10-10 2008-04-17 The Regents Of The University Of Michigan Photoreceptor precursor cells
JP2010508855A (ja) * 2006-11-08 2010-03-25 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌マーカーとしてのｓｐｉｎｋ１およびその使用
WO2008092002A2 (en) 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US20090324596A1 (en) 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
SI2173379T1 (sl) 2007-07-02 2015-12-31 Oncomed Pharmaceuticals, Inc. Sestavki in postopki za zdravljenje in diagnosticiranje raka
WO2009009432A2 (en) 2007-07-06 2009-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
CA2692793C (en) 2007-07-06 2014-05-20 The Regents Of The University Of Michigan Mipol1-etv1 gene rearrangements
WO2009111644A2 (en) * 2008-03-05 2009-09-11 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating pancreatic cancer
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
DK2331136T3 (da) 2008-09-26 2018-03-05 Oncomed Pharm Inc Frizzled-bindende midler og anvendelser deraf
CN102272599B (zh) 2008-11-11 2015-01-14 密执安大学评议会 抗cxcr1组合物和方法
CN102639709A (zh) 2009-01-09 2012-08-15 密歇根大学董事会 癌症中的复现性基因融合体
JP5800817B2 (ja) 2009-09-17 2015-10-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌における再発性遺伝子融合
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Ｗｎｔ拮抗劑及治療和篩選方法
EP2548025A4 (en) 2010-03-17 2013-09-25 Univ Michigan USE OF PHOTOEPITOPES FOR PROFILING AN IMMUNE REACTION
AU2011235904B2 (en) 2010-04-01 2015-10-08 Oncomed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
BRPI1003970B1 (pt) * 2010-10-29 2020-05-05 Univ Federal Do Rio De Janeiro Ufrj processo de marcação com radionuclídeos de anticorpos murinos ou humanos, monoclonais ou policlonais anti-fator de necrose tumoral associados a doenças cuja fisiopatogenia envolva fator de necrose tumoral; reagente para diagnóstico "in vivo" e/ou "in vitro" a base de anticorpos murinos ou humanos, monoclonais ou policlonais anti-fator de necrose tumoral associados à radionuclídeos; métodos de diagnóstico "in vitro" e/ou "in vivo" de doenças cuja fisiotopagenia envolva fator de necrose tumoral utilizando o reagente assim obtido e kit para diagnóstico de doenças cuja fisiopatogenia envolva fator de necrose tumoral a base do referido reagente
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
EP2640854B1 (en) 2010-11-19 2018-02-21 The Regents Of The University Of Michigan PCAT1 ncRNA AND USES THEREOF
US8668900B2 (en) 2011-02-15 2014-03-11 Kuwait University Cancer-imaging agent and method of radioimaging using the same
EP2795333A4 (en) 2011-12-20 2016-02-17 Univ Michigan PSEUDOGENS AND USES THEREOF
US9506117B2 (en) 2012-02-21 2016-11-29 Oslo Universitetssykehus Hf Methods and biomarkers for detection and prognosis of cervical cancer
WO2013132354A2 (en) 2012-03-06 2013-09-12 Oslo Universitetssykehus Hf Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer
US11035005B2 (en) 2012-08-16 2021-06-15 Decipher Biosciences, Inc. Cancer diagnostics using biomarkers
WO2014066328A1 (en) 2012-10-23 2014-05-01 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
CA2899353A1 (en) 2013-02-04 2014-08-07 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
US11873532B2 (en) 2017-03-09 2024-01-16 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992514A (en) * 1972-07-17 1976-11-16 Istituto Farmacologico Serono S.P.A. Radioimmunoassay method for human chorionic gonadotropin in the presence of luteinizing hormone
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4010251A (en) * 1974-12-16 1977-03-01 Green Allan M Scanning agent composition and use in imaging liver and for biliary function
FR2310748A1 (fr) * 1975-05-15 1976-12-10 Abramovici J Procede de marquage de proteines a l'aide du technetium
US4150149A (en) * 1976-11-29 1979-04-17 Professional Staff Association Of The Los Angeles County Harbor General Hospital Method and means for the early detection and diagnosis of certain types of cancers

Also Published As

Publication number Publication date
CA1116081A (en) 1982-01-12
IL57348A (en) 1982-07-30
EP0005638A2 (en) 1979-11-28
DE2966177D1 (en) 1983-10-27
EP0005638B1 (en) 1983-09-21
EP0005638A3 (en) 1979-12-12
US4323546A (en) 1982-04-06

Similar Documents

Publication Publication Date Title
DK207379A (da) Technetium-99-maerket anti-humant-choriongonadotropin, technetium-99m-maerket anti-humant-choriongonadotropin-beta eller blandinger deraf samt diagnostisk saet til fremstilling af et middel til identifikation af en cancercelle og eller en malign t
DK453279A (da) Daase eller flaskepakning og femgangsmaade til fremstilling af en saadan
DK421879A (da) Formstofnet og fremgangsmaade til fremstilling af dette
NL181301C (nl) Spectrofotometer.
BR7903329A (pt) Aeronave
DK421979A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK475179A (da) Apparat til rengoering af oldrette eller skraa flader
NL7903984A (nl) Vaste-fase-analyse.
NL182126C (nl) Laboratoriumcentrifuge.
DK161298C (da) Fremgangsmaade til foroegelse af tvaerforgrening, skuddannelse, blomstring og udbytte af afgroeder i land- og havebrug og til fremskyndelse af modning af kornafgroeder samt middel til anvendelse ved fremgangsmaaden til foroegelse af afgroedeudbyttet af kornsorter eller baelgfrugter
DK547577A (da) Mikrobedraebende eller haemmende middel
IT7927311A0 (it) Derivati spiro-policiclicimidazolidinadionici.
NO794120L (no) Helikopter.
IT7925083A0 (it) Derivati di cloroambucile.
DK446979A (da) Fungicidt eller herbicidt middel
NO780478L (no) Null-detektor.
DK220683A (da) Indretning til transport eller flytning af isaer langstrakte genstande samt i indretningen indgaaende traekhjul
NL7811501A (nl) Kuipelement.
NO153154C (no) Anslagstenner med flyvetidsavhengig forsinkelsestid.
NO822727L (no) Fallskjermkalott.
IT7927341A0 (it) Rivelatore.
NO147222C (no) Vindu eller klaff.
IT7920543A0 (it) Derivati benzilidenici.
NL7900310A (nl) Detectorketen.
DK136581A (da) Fremgansmaade til fremstilling af insulin eller et hermed analogt produkt